Question 1

What is the catalog number for NFE2L2 (Nuclear Factor (erythroid-Derived 2) -like 2, NRF2) (Biotin)?

Accepted Answer

The catalog number for NFE2L2 (Nuclear Factor (erythroid-Derived 2) -like 2, NRF2) (Biotin) is 249281-Biotin.

Question 2

What sizes are available for NFE2L2 (Nuclear Factor (erythroid-Derived 2) -like 2, NRF2) (Biotin)?

Accepted Answer

NFE2L2 (Nuclear Factor (erythroid-Derived 2) -like 2, NRF2) (Biotin) is available in the following size(s): 100 µL.

Question 3

Is NFE2L2 (Nuclear Factor (erythroid-Derived 2) -like 2, NRF2) (Biotin) in stock?

Accepted Answer

NFE2L2 (Nuclear Factor (erythroid-Derived 2) -like 2, NRF2) (Biotin) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 5

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Question 6

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

NFE2L2 (Nuclear Factor (erythroid-Derived 2) -like 2, NRF2) (Biotin)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

ID3 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI7B6]

Recombinant Human HMGB1 protein (His Tag)

Recombinant Human HMGB1 protein (His Tag)

Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker) (CPA1/2711), CF405S conjugate, 0.1mg/mL

Formic Acid-13C

SHOX2 (NM_006884) Human Recombinant Protein